Tailored Fall prevention exergaming, helping improve uptake and long term self management of Standing Strength and Balance among elderly Populations, and the NHS Reduce Costs
Tailored Fall prevention exergaming, helping improve uptake and long term self management of Standing Strength and Balance among elderly Populations, and the NHS Reduce Costs
批准号:
10036275
负责人:
金额:
$44.15万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
eXyo是一家总部位于英国的SME,旨在解决缺乏有效的跌倒预防治疗解决方案的问题。这种缺乏在65岁以上的人口中感受最深,其中三分之一预计每年至少跌倒一次。年龄英国已确定福尔斯的主要原因伤害和死亡的65岁以上。新冠肺炎和相关限制给这一人群和相关的NHS福尔斯服务造成了相当大的额外压力,并增加了跌倒率。由于人口迅速老龄化,下降率将继续上升;到2050年,目前60岁以上的人数将增加一倍,80岁以上的人数将增加两倍。eXyo的核心团队由Andrew Morgan、Christopher Hughes和Jonathan Charlesworth组成,他们在产品设计、业务开发、临床开发和机械工程方面经验丰富,专门从事康复技术。eXyo正在开发一种站立/平衡康复辅助设备,便于远程监督和游戏化治疗。根据这项研究,eXyo的最终产品只有1%的市场份额,到2027年,通过减少福尔斯,每年可以为NHS节省1480万英镑。
英文摘要
eXyo is a UK-based SME that intends to address the issue of a lack of effective therapy solutions for fall prevention. This lack is most felt in the over-65 population, a third of whom are expected to suffer at least one fall annually. Age UK have identified falls as the leading cause of injury and death for over 65s. Covid-19 and the associated restrictions have caused considerable additional strain for this population and the associated NHS falls services and have increased fall rates. Fall rates shall continue to rise due to the rapidly ageing population; current numbers of over 60s will double, and over 80s will triple by 2050\. eXyo's core team, comprises Andrew Morgan, Christopher Hughes and Jonathan Charlesworth, who are experienced in product design, business development, clinical development and mechanical engineering specialising in rehabilitative technologies. eXyo are developing a standing/balance rehabilitation aid that facilitates remote supervision and gamified therapy. Implementation of eXyo's end product with just 1% market share, as informed by this research, could save the NHS £14.8M annually by 2027 through reducing falls.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金